Green Cross Holdings Preference Shares Asset Resilience Ratio
Green Cross Holdings Preference Shares asset resilience ratio. Green Cross Holdings Preference Shares (005257) has an Asset Resilience Ratio of 0.54% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Green Cross Holdings Preference Shares (005257) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Green Cross Holdings Preference Shares (2013–2025)
Asset resilience ratio of Green Cross Holdings Preference Shares from 2013 to 2025. This chart shows how Green Cross Holdings Preference Shares's Asset Resilience Ratio has changed over time. Read Green Cross Holdings Preference Shares balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Green Cross Holdings Preference Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 005257 current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩22.38 Billion | 0.54% |
| Total Liquid Assets | ₩22.38 Billion | 0.54% |
Asset Resilience Insights
- Limited Liquidity: Green Cross Holdings Preference Shares maintains only 0.54% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Green Cross Holdings Preference Shares Industry Peers by Asset Resilience Ratio
Compare Green Cross Holdings Preference Shares's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GT Biopharma Inc
NASDAQ:GTBP |
Biotechnology | 0.00% |
|
Kura Oncology Inc
NASDAQ:KURA |
Biotechnology | 76.35% |
|
Sprint Bioscience AB
ST:SPRINT |
Biotechnology | 77.81% |
|
Herantis Pharma Oyj
HE:HRTIS |
Biotechnology | 89.18% |
|
Suzhou Fushilai Pharmaceutical Co. Ltd.
SHE:301258 |
Biotechnology | 45.84% |
|
Inventiva S.A
PA:IVA |
Biotechnology | 52.73% |
|
Sinocelltech Group Ltd
SHG:688520 |
Biotechnology | 5.27% |
|
Argenica Therapeutics Ltd
AU:AGN |
Biotechnology | 0.52% |
Green Cross Holdings Preference Shares Asset Resilience Ratio by Year (2013–2025)
Green Cross Holdings Preference Shares asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Green Cross Holdings Preference Shares.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.48% | ₩19.63 Billion ≈ $13.30 Million |
₩4.07 Trillion ≈ $2.76 Billion |
+0.30pp |
| 2024-12-31 | 0.19% | ₩6.79 Billion ≈ $4.60 Million |
₩3.67 Trillion ≈ $2.49 Billion |
-0.39pp |
| 2023-12-31 | 0.58% | ₩21.57 Billion ≈ $14.62 Million |
₩3.74 Trillion ≈ $2.53 Billion |
-0.30pp |
| 2022-12-31 | 0.87% | ₩31.34 Billion ≈ $21.24 Million |
₩3.59 Trillion ≈ $2.43 Billion |
-0.92pp |
| 2021-12-31 | 1.80% | ₩62.83 Billion ≈ $42.58 Million |
₩3.50 Trillion ≈ $2.37 Billion |
-0.13pp |
| 2020-12-31 | 1.92% | ₩62.35 Billion ≈ $42.25 Million |
₩3.24 Trillion ≈ $2.20 Billion |
+0.28pp |
| 2019-12-31 | 1.64% | ₩45.49 Billion ≈ $30.82 Million |
₩2.77 Trillion ≈ $1.88 Billion |
+0.86pp |
| 2018-12-31 | 0.78% | ₩20.53 Billion ≈ $13.91 Million |
₩2.63 Trillion ≈ $1.78 Billion |
+0.66pp |
| 2017-12-31 | 0.12% | ₩3.07 Billion ≈ $2.08 Million |
₩2.56 Trillion ≈ $1.74 Billion |
-3.81pp |
| 2016-12-31 | 3.93% | ₩88.35 Billion ≈ $59.87 Million |
₩2.25 Trillion ≈ $1.52 Billion |
+0.30pp |
| 2015-12-31 | 3.63% | ₩74.66 Billion ≈ $50.59 Million |
₩2.06 Trillion ≈ $1.40 Billion |
-0.28pp |
| 2014-12-31 | 3.90% | ₩69.89 Billion ≈ $47.37 Million |
₩1.79 Trillion ≈ $1.21 Billion |
+1.72pp |
| 2013-12-31 | 2.19% | ₩35.51 Billion ≈ $24.06 Million |
₩1.62 Trillion ≈ $1.10 Billion |
-- |
About Green Cross Holdings Preference Shares
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and… Read more